← Leaderboards
James Brugarolas
Dana-Farber Cancer Institute
$10,657,328
Attributed
$10,657,328
Total exposure
12
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$30,669,682 · 13
By mechanism
P50$26,179,498 · 9
R01$3,252,439 · 2
K08$820,758 · 1
R21$416,987 · 1
Top collaborators
- Payal Kapur4 shared
Most similar at Dana-Farber Cancer Institute
Same institution · by research overlap
- James L M Ferrara$21,206,325
- William G Kaelin$28,163,102
Others in their field
Top investigators on “Renal Carcinoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$97,125,175
- Ian M Thompson · University Of Texas Hlth Sci Ctr San Ant$23,354,043
- John James McNeil · Hennepin Healthcare Research Institute$22,201,424
- John H Sampson · Duke University$19,179,772
- William G Kaelin · Dana-Farber Cancer Institute$18,573,699
- Richard H Grimm · University Of Minnesota Twin Cities$17,709,591
Research focus
Renal CarcinomaInnovationTumorMedical CenterUniversitiesTexasProgramsGenesResearch PersonnelReportingEvaluationRenal Cell CarcinomaTranslationsTranslatingFundingMutationResearch StudyCollaborationsProteinsFoundationsMalignant NeoplasmsTranscription FactorSuccessMediating
Grant awards (53)
University of Texas Southwestern Medical Center SPORE in Kidney Cancer$2,336,997
P50 · FY2025 · CA · contact PI
Core A: Administrative Core$259,667
P50 · FY2025 · CA · contact PI
Project 1: Targeting HIF2 in Renal Cell Carcinoma$259,667
P50 · FY2025 · CA · contact PI
Developmental Research Program$259,666
P50 · FY2025 · CA · contact PI
University of Texas Southwestern Medical Center SPORE in Kidney Cancer$2,243,520
P50 · FY2024 · CA · contact PI
Project 1: Targeting HIF2 in Renal Cell Carcinoma$347,133
P50 · FY2024 · CA · contact PI
Developmental Research Program$214,340
P50 · FY2024 · CA · contact PI
Core A: Administrative Core$153,719
P50 · FY2024 · CA · contact PI
University of Texas Southwestern Medical Center SPORE in Kidney Cancer$2,173,408
P50 · FY2023 · CA · contact PI
Project 1: Targeting HIF2 in Renal Cell Carcinoma$339,342
P50 · FY2023 · CA · contact PI
Developmental Research Program$206,550
P50 · FY2023 · CA · contact PI
Core A: Administrative Core$145,930
P50 · FY2023 · CA · contact PI
University of Texas Southwestern Medical Center SPORE in Kidney Cancer$2,173,410
P50 · FY2022 · CA · contact PI
Project 1: Targeting HIF2 in Renal Cell Carcinoma$332,494
P50 · FY2022 · CA · contact PI
Dissecting the mechanism of cabozantinib anti-tumor effect in renal cancer$225,410
R21 · FY2022 · CA · contact PI
Developmental Research Program$208,995
P50 · FY2022 · CA · contact PI
Core A: Administrative Core$152,621
P50 · FY2022 · CA · contact PI
Dissecting the mechanism of cabozantinib anti-tumor effect in renal cancer$191,577
R21 · FY2021 · CA · contact PI
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer$2,185,000
P50 · FY2020 · CA · contact PI
Project 1: Targeting HIF-2 for the Treatment of Clear-Cell Renal Cell Carcinoma$321,476
P50 · FY2020 · CA · contact PI
Developmental Research Program$180,905
P50 · FY2020 · CA · contact PI
Core A: Administrative Core$177,643
P50 · FY2020 · CA · contact PI
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer$2,138,019
P50 · FY2019 · CA · contact PI
Project 1: Targeting HIF-2 for the Treatment of Clear-Cell Renal Cell Carcinoma$296,485
P50 · FY2019 · CA · contact PI
Developmental Research Program$166,562
P50 · FY2019 · CA · contact PI
Core A: Administrative Core$163,722
P50 · FY2019 · CA · contact PI
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer$2,300,000
P50 · FY2018 · CA · contact PI
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma$329,925
R01 · FY2018 · CA · contact PI
Project 1: Targeting HIF-2 for the Treatment of Clear-Cell Renal Cell Carcinoma$318,715
P50 · FY2018 · CA · contact PI
Developmental Research Program$179,349
P50 · FY2018 · CA · contact PI
Core A: Administrative Core$176,112
P50 · FY2018 · CA · contact PI
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer$2,300,000
P50 · FY2017 · CA · contact PI
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma$329,925
R01 · FY2017 · CA · contact PI
Project 1: Targeting HIF-2 for the Treatment of Clear-Cell Renal Cell Carcinoma$318,713
P50 · FY2017 · CA · contact PI
Developmental Research Program$179,349
P50 · FY2017 · CA · contact PI
Core A: Administrative Core$176,114
P50 · FY2017 · CA · contact PI
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer$2,162,000
P50 · FY2016 · CA · contact PI
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma$329,925
R01 · FY2016 · CA · contact PI
Project 1: Targeting HIF-2 for the Treatment of Clear-Cell Renal Cell Carcinoma$300,075
P50 · FY2016 · CA · contact PI
Developmental Research Program$168,543
P50 · FY2016 · CA · contact PI
Core A: Administrative Core$163,257
P50 · FY2016 · CA · contact PI
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma$329,925
R01 · FY2015 · CA · contact PI
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma$329,925
R01 · FY2014 · CA · contact PI
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein$316,002
R01 · FY2012 · CA · contact PI
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein$316,002
R01 · FY2011 · CA · contact PI
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein$325,775
R01 · FY2010 · CA · contact PI
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein$325,775
R01 · FY2009 · CA · contact PI
VEGF regulation by the TSC2 tumor suppressor$173,173
K08 · FY2009 · NS · contact PI
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein$319,260
R01 · FY2008 · CA · contact PI
VEGF regulation by the TSC2 tumor suppressor$172,976
K08 · FY2008 · NS · contact PI
VEGF regulation by the TSC2 tumor suppressor$172,786
K08 · FY2007 · NS · contact PI
VEGF regulation by the TSC2 tumor suppressor$151,001
K08 · FY2006 · NS · contact PI
VEGF regulation by the TSC2 tumor suppressor$150,822
K08 · FY2005 · NS